171 results
Page 3 of 9
8-K
EX-99.1
7q0moj puv
9 May 22
Adaptimmune Reports First Quarter Financial Results and Business Update
7:40am
8-K
EX-99.1
60v lxj3xnj
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
8-K
EX-99.1
529i a8z0636613xqhn
14 Mar 22
Adaptimmune Reports Fourth Quarter and Full Year 2021 Financial Results and Business Update
8:06am
8-K
EX-99.1
txdfna1omwl
26 Jan 22
Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer
8:05am
8-K
EX-99.1
am0n3fq79qkddcscd8z6
12 Nov 21
Adaptimmune Reports Positive Results from its Pivotal SPEARHEAD-1 Trial in Patients with Synovial Sarcoma and MRCLS at CTOS
6:30am
8-K
EX-99.1
qsdbxzx2a6mvecbwm03
4 Nov 21
Adaptimmune Reports Third Quarter Financial Results and Business Update
7:40am
8-K
EX-99.1
72t2qdwd1c dwg1ohp
13 Sep 21
Other Events
7:08am
8-K
EX-99.1
tw40ym6ua6ybsfbg
7 Sep 21
Adaptimmune Enters into a Strategic Collaboration with Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies
7:08am
8-K
EX-99.1
jilu4g3923l
9 Aug 21
Adaptimmune Reports Second Quarter Financial Results and Business Update
4:08pm
8-K
EX-99.1
uoka99vtllg
19 May 21
Two Complete Responses and Response Rate of 41% for People with Synovial Sarcoma Reported at ASCO in Adaptimmune’s Phase 2 SPEARHEAD-1 Trial
5:08pm
8-K
EX-99.1
pjwmdd 9t4
6 May 21
Adaptimmune Reports First Quarter Financial Results and Business Update
7:38am